Senior Corporate Development Analyst

Amneal

1d•$80,000 - $105,000

About The Position

The Senior Corporate Development Analyst is a high impact individual contributor role within a fast paced Corporate Development team operating at the intersection of finance, strategy, and commercial development. This role independently supports deal evaluation and strategic analysis across licensing, partnerships, and M&A opportunities, partnering closely with senior leaders to inform investment decisions.The Senior Analyst is expected to own complex analyses, exercise sound judgment, and synthesize insights into executive ready recommendations, playing a key role in how the company evaluates and prioritizes strategic opportunities.

Requirements

Experience supporting licensing, partnership, or M&A evaluations with increasing independence and judgment.
Exposure to pharmaceutical or healthcare industry dynamics, including familiarity with generics, branded pharmaceuticals, biosimilars, or FDA regulatory pathways.
Advanced Excel proficiency, including the ability to build and audit financial models from scratch.
Strong PowerPoint and storytelling skills, with the ability to communicate complex analysis clearly and succinctly to senior stakeholders.
Working knowledge of SQL for querying and analyzing large, complex datasets.
Proven ability to manage multiple analytical workstreams simultaneously in a fast paced, deadline driven environment.
Strong written and verbal communication skills, with confidence engaging cross functional partners and senior leaders.
Demonstrated ownership mindset - intellectually curious, proactive, and comfortable operating in ambiguous situations.
Bachelor's Degree (BA/BS) bachelor’s degree required
4-8 years of experience in corporate development, FP&A, strategy, investment banking, consulting, or a similarly analytical role
Experience with valuation methodologies, including DCF, comparable transactions, royalty-based deal structures, or risk adjusted valuation approaches.
Demonstrated ability to translate analysis into recommendations that influence strategic or investment decisions.

Nice To Haves

Master's degree (MS/MA) Advanced degree (MBA or MS) a plus

Responsibilities

Independently build, refine, and maintain complex financial models to evaluate licensing deals, partnerships, and M&A opportunities, including cash flow analysis, NPV/IRR calculations, sensitivity analysis, and scenario modeling.
Conduct advanced market and competitive research, analyzing industry trends, pipeline activity, new drug approvals, and ANDA dynamics to identify and assess growth opportunities.
Own deal pipeline analytics and reporting, ensuring accurate tracking of opportunities, transaction assumptions, risks, and key milestones for leadership visibility.
Develop clear, executive ready presentations that translate complex financial and strategic analysis into actionable insights for senior leadership, partners, and governance forums.
Design and maintain dashboards and visualizations using BI tools (e.g., Power BI, Tableau) to monitor deal flow, market trends, and portfolio performance.
Leverage SQL to extract, manipulate, and analyze large datasets, supporting deep dive analysts of commercial, financial, and operational performance.
Collaborate cross functionally with Commercial, Finance, Regulatory, Legal, and R&D teams to integrate inputs and develop comprehensive, well structured business cases.
Support preparation of materials for executive leadership and Board level reviews, including investment recommendations, valuation summaries, and strategic narratives.
Apply enterprise financial systems and tools (e.g., Oracle Hyperion EPM, SQL based platforms) to analyze top and bottom line performance across product portfolios.
Partner with Finance to support forecasting and long range planning, contributing analytical insights to inform achievable yet ambitious growth targets.
Identify opportunities to enhance analytical rigor, modeling approaches, and reporting efficiency within the Corporate Development function.